_1777294237270_124456903.png&w=64&q=75){kind=small}
Avallon Pharma to Develop Medicines in Saudi Arabia
Avalon Pharma announced the signing of a memorandum of understanding with Chinese Orisco Pharma to develop and manufacture complex medicines in Saudi Arabia. This move is part of its efforts to transfer technology and localize production in the field of RNA-based drugs. The initiative includes an initial project named "Enclisiran," aiming to establish a broader platform for complex pharmaceutical products, with a focus on manufacturing in Riyadh to support Saudi Vision 2030. The memorandum is valid for six months and involves negotiations regarding commercial and financial terms, without specifying an current financial value. This step is part of Avalon Pharma's strategy to strengthen its capabilities in the rapidly evolving field of oligonucleotides.
Notice: This Is an AI-Generated Summary
Comments (0)